Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers Journal Article


Authors: Offin, M.; Somwar, R.; Rekhtman, N.; Benayed, R.; Chang, J. C.; Plodkowski, A.; Lui, A. J. W.; Eng, J.; Rosenblum, M.; Li, B. T.; Riely, G. J.; Rudin, C. M.; Kris, M. G.; Travis, W.; Drilon, A.; Arcila, M. E.; Ladanyi, M.; Yu, H. A.
Article Title: Acquired ALK and RET gene fusions as mechanisms of resistance to osimertinib in EGFR-mutant lung cancers
Keywords: mutation; tyrosine kinase inhibitors
Journal Title: JCO Precision Oncology
Volume: 2
ISSN: 2473-4284
Publisher: American Society of Clinical Oncology  
Date Published: 2018-01-01
Language: English
ACCESSION: WOS:000462148900001
DOI: 10.1200/po.18.00126
PROVIDER: wos
PMCID: PMC6447364
PUBMED: 30957057
Notes: Source: Wos
Altmetric Score
MSK Authors
  1. Natasha Rekhtman
    221 Rekhtman
  2. Marc Rosenblum
    259 Rosenblum
  3. Helena Alexandra Yu
    97 Yu
  4. Marc Ladanyi
    897 Ladanyi
  5. William D Travis
    554 Travis
  6. Gregory J Riely
    361 Riely
  7. Romel Somwar
    40 Somwar
  8. Maria Eugenia Arcila
    360 Arcila
  9. Mark Kris
    629 Kris
  10. Alexander Edward Drilon
    158 Drilon
  11. Juliana Wai Ming Eng
    17 Eng
  12. Charles Rudin
    175 Rudin
  13. Rym Benayed
    81 Benayed
  14. Jason Chih-Peng Chang
    18 Chang
  15. Bob Tingkan Li
    70 Li
  16. Michael David Offin
    23 Offin
  17. Jo Weng Allan Lui
    1 Lui